Presence & RecognitionEvent: September 2, 2026
Pan.bio held its first Journal Club session mapping the path to clinical multi-omics by Dr. Said Ismail.
Published
Signal category
Presence & Recognition
Quote
“In the first Pan.bio Journal Club session, Dr. Said Ismail maps out the path to clinical multi-omics”
— Pan.bio team
Company
Pan.bio
End-to-end bioinformatics platform.
- Industry
- Biotechnology Research
- Location
- Boston, US
- Company size
- 18 employees
Pan.bio is the AI-powered, end-to-end genomics platform connecting bioinformatics workflows, variant interpretation, and patient cohort data, all in one place.
Founded 2022